• Culture, Acid-Fast Bacilli, Bronchoalveolar Lavage
  • Smooth Muscle Antibody
  • Activated Protein C Resistance V (APCRV)
  • Coxsackie A Virus Antobody, Serum
  • Beta-amyloid (Aβ1-40 and Aβ1-42), Plasma
  • Lactate Dehydrogenase (LDH), Serum
  • Breast Cancer Antigen CA 15-3
  • Anaplasma phagocytophilum Antibody, IgG, IgM
  • Des-Gamma-Carboxy Prothrombin (DCP), Serum
  • Succinate Dehydrogenase (SDHA, SDHB, SDHC and SDHD) Gene Mutation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Aspartoacylase (ASPA) Gene Mutation Analysis (Canavan Disease)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Aspartoacylase (ASPA) Gene Mutation Analysis (Canavan Disease)
Medical Test

Additional ICD10
Access to Aspartoacylase (ASPA) Gene Mutation Analysis (Canavan Disease) is restricted.
Loading...